Clinical trials
Muscular Dystrophy, Duchenne trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 11 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarepta Therapeutics, Inc. | 7 |
| PTC Therapeutics | 6 |
| GlaxoSmithKline | 3 |
| Italfarmaco | 3 |
| Santhera Pharmaceuticals | 3 |
| BioMarin Pharmaceutical | 2 |
| Catabasis Pharmaceuticals | 2 |
| Edgewise Therapeutics, Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Avidity Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophy, Duchenne | 40 |
| Muscular Dystrophies | 15 |
| Neuromuscular Diseases | 7 |
| Muscular Diseases | 5 |
| Musculoskeletal Diseases | 5 |
| Genetic Diseases, Inborn | 3 |
| Muscular Disorders, Atrophic | 3 |
| Nervous System Diseases | 3 |
| Genetic Diseases, X-Linked | 2 |
| Myotonic Dystrophy | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.